Concepts (231)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy Complications, Infectious | 7 | 2024 | 2185 | 0.720 |
Why?
|
HIV Infections | 24 | 2024 | 17575 | 0.710 |
Why?
|
Acquired Immunodeficiency Syndrome | 3 | 2023 | 2202 | 0.640 |
Why?
|
Periodontal Diseases | 5 | 2020 | 455 | 0.600 |
Why?
|
Infectious Disease Transmission, Vertical | 9 | 2024 | 1360 | 0.470 |
Why?
|
Anti-HIV Agents | 5 | 2024 | 4571 | 0.460 |
Why?
|
Anti-Retroviral Agents | 4 | 2024 | 1794 | 0.300 |
Why?
|
Neck Dissection | 1 | 2009 | 201 | 0.290 |
Why?
|
Observation | 1 | 2009 | 311 | 0.290 |
Why?
|
Tongue Neoplasms | 1 | 2009 | 186 | 0.280 |
Why?
|
Carcinoma, Hepatocellular | 7 | 2014 | 2331 | 0.260 |
Why?
|
Papillomaviridae | 3 | 2019 | 1140 | 0.250 |
Why?
|
Saliva | 2 | 2020 | 854 | 0.230 |
Why?
|
Liver Neoplasms | 7 | 2014 | 4360 | 0.200 |
Why?
|
Pregnancy Trimester, Third | 1 | 2024 | 584 | 0.190 |
Why?
|
Benzenesulfonates | 2 | 2012 | 165 | 0.190 |
Why?
|
Papillomavirus Infections | 3 | 2019 | 1640 | 0.170 |
Why?
|
Papillomavirus Vaccines | 2 | 2019 | 497 | 0.170 |
Why?
|
Gingival Crevicular Fluid | 1 | 2019 | 96 | 0.160 |
Why?
|
Stomatognathic Diseases | 1 | 2018 | 21 | 0.160 |
Why?
|
Marijuana Smoking | 1 | 2021 | 259 | 0.150 |
Why?
|
Noise | 1 | 2020 | 292 | 0.140 |
Why?
|
Adiponectin | 2 | 2016 | 1117 | 0.140 |
Why?
|
Language Development Disorders | 1 | 2018 | 193 | 0.140 |
Why?
|
Pregnancy | 10 | 2024 | 30198 | 0.130 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2020 | 2537 | 0.130 |
Why?
|
Tooth Diseases | 1 | 2016 | 73 | 0.130 |
Why?
|
Antibodies, Viral | 2 | 2019 | 3211 | 0.130 |
Why?
|
Language Disorders | 1 | 2016 | 140 | 0.130 |
Why?
|
Chickenpox Vaccine | 1 | 2015 | 40 | 0.130 |
Why?
|
Cohort Studies | 12 | 2023 | 41791 | 0.130 |
Why?
|
Hearing Loss | 1 | 2023 | 786 | 0.130 |
Why?
|
Mouth Mucosa | 1 | 2018 | 437 | 0.120 |
Why?
|
Fatigue Syndrome, Chronic | 1 | 2016 | 217 | 0.120 |
Why?
|
Chickenpox | 1 | 2015 | 96 | 0.120 |
Why?
|
Speech Perception | 1 | 2020 | 512 | 0.120 |
Why?
|
Postpartum Period | 1 | 2021 | 1197 | 0.120 |
Why?
|
Carnitine | 1 | 2016 | 254 | 0.120 |
Why?
|
Child | 17 | 2024 | 80894 | 0.120 |
Why?
|
Otoacoustic Emissions, Spontaneous | 1 | 2015 | 139 | 0.120 |
Why?
|
Dental Caries | 1 | 2018 | 429 | 0.110 |
Why?
|
Receptors, CCR5 | 1 | 2016 | 491 | 0.110 |
Why?
|
Mouth Diseases | 1 | 2016 | 239 | 0.110 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2020 | 783 | 0.110 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2020 | 1903 | 0.110 |
Why?
|
Adolescent | 21 | 2024 | 89182 | 0.110 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2009 | 4069 | 0.110 |
Why?
|
Periodontitis | 1 | 2018 | 577 | 0.100 |
Why?
|
Cytomegalovirus Infections | 1 | 2019 | 839 | 0.100 |
Why?
|
Young Adult | 16 | 2024 | 60048 | 0.100 |
Why?
|
Cross-Sectional Studies | 11 | 2024 | 26373 | 0.090 |
Why?
|
Female | 35 | 2024 | 397050 | 0.090 |
Why?
|
Bacteria | 2 | 2020 | 2222 | 0.090 |
Why?
|
Insulin Resistance | 1 | 2024 | 3981 | 0.090 |
Why?
|
Pyridines | 2 | 2012 | 2889 | 0.080 |
Why?
|
Chi-Square Distribution | 3 | 2014 | 3438 | 0.080 |
Why?
|
Viral Load | 4 | 2022 | 3398 | 0.080 |
Why?
|
Peritoneal Dialysis | 1 | 2010 | 160 | 0.080 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2009 | 128 | 0.080 |
Why?
|
Alcohol Drinking | 1 | 2021 | 4049 | 0.080 |
Why?
|
Maternal Exposure | 1 | 2016 | 1079 | 0.080 |
Why?
|
Adult | 25 | 2024 | 223622 | 0.080 |
Why?
|
Child, Preschool | 6 | 2023 | 42654 | 0.080 |
Why?
|
Pregnancy Complications | 1 | 2021 | 2971 | 0.070 |
Why?
|
Humans | 41 | 2024 | 768298 | 0.070 |
Why?
|
Hong Kong | 3 | 2014 | 168 | 0.070 |
Why?
|
Audiovisual Aids | 1 | 2007 | 99 | 0.070 |
Why?
|
Neoplasm Staging | 2 | 2014 | 11254 | 0.070 |
Why?
|
CD4 Lymphocyte Count | 3 | 2018 | 2596 | 0.070 |
Why?
|
Sympathetic Nervous System | 1 | 2008 | 521 | 0.060 |
Why?
|
Patient Simulation | 1 | 2007 | 297 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 3 | 2014 | 6541 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3836 | 0.060 |
Why?
|
Shock | 1 | 2007 | 316 | 0.060 |
Why?
|
Male | 26 | 2024 | 364870 | 0.060 |
Why?
|
Disease-Free Survival | 3 | 2011 | 6856 | 0.060 |
Why?
|
Fungemia | 1 | 2005 | 57 | 0.060 |
Why?
|
Candida | 1 | 2005 | 171 | 0.060 |
Why?
|
Electron Transport Complex IV | 1 | 2024 | 192 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2014 | 2005 | 0.060 |
Why?
|
Pyruvic Acid | 1 | 2024 | 205 | 0.050 |
Why?
|
Health Status Indicators | 1 | 2008 | 971 | 0.050 |
Why?
|
Electron Transport Complex I | 1 | 2024 | 153 | 0.050 |
Why?
|
Respiratory Tract Diseases | 1 | 2008 | 748 | 0.050 |
Why?
|
Survival Analysis | 3 | 2009 | 10117 | 0.050 |
Why?
|
Candidiasis | 1 | 2005 | 367 | 0.050 |
Why?
|
Oxidative Phosphorylation | 1 | 2024 | 501 | 0.050 |
Why?
|
Reference Values | 1 | 2009 | 4941 | 0.050 |
Why?
|
Sleep Apnea Syndromes | 1 | 2010 | 982 | 0.050 |
Why?
|
Area Under Curve | 3 | 2014 | 1642 | 0.050 |
Why?
|
Liver Cirrhosis | 1 | 2012 | 1957 | 0.050 |
Why?
|
Prospective Studies | 6 | 2024 | 54921 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2009 | 1795 | 0.050 |
Why?
|
Patient Selection | 2 | 2014 | 4265 | 0.050 |
Why?
|
Phosphates | 1 | 2024 | 766 | 0.040 |
Why?
|
Bone Remodeling | 1 | 2024 | 583 | 0.040 |
Why?
|
Thalidomide | 1 | 2006 | 886 | 0.040 |
Why?
|
Serologic Tests | 1 | 2022 | 383 | 0.040 |
Why?
|
HIV | 2 | 2018 | 1596 | 0.040 |
Why?
|
Niacinamide | 2 | 2012 | 417 | 0.040 |
Why?
|
HIV Seroprevalence | 1 | 2019 | 89 | 0.040 |
Why?
|
Condylomata Acuminata | 1 | 2019 | 79 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2024 | 14783 | 0.040 |
Why?
|
Viremia | 1 | 2022 | 725 | 0.040 |
Why?
|
Osteoporosis | 1 | 2009 | 1606 | 0.040 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2011 | 2044 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2010 | 2103 | 0.040 |
Why?
|
Hearing | 1 | 2023 | 502 | 0.040 |
Why?
|
Lactic Acid | 1 | 2024 | 1140 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2012 | 13696 | 0.040 |
Why?
|
HIV Seronegativity | 1 | 2019 | 210 | 0.040 |
Why?
|
HIV-1 | 1 | 2016 | 6963 | 0.040 |
Why?
|
Phenylurea Compounds | 2 | 2012 | 529 | 0.040 |
Why?
|
ROC Curve | 3 | 2014 | 3622 | 0.040 |
Why?
|
Puerto Rico | 1 | 2019 | 380 | 0.040 |
Why?
|
Education, Medical, Undergraduate | 1 | 2007 | 1082 | 0.040 |
Why?
|
Middle Aged | 15 | 2016 | 223463 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2011 | 4047 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2020 | 997 | 0.030 |
Why?
|
Diagnosis, Oral | 1 | 2016 | 23 | 0.030 |
Why?
|
Cardiology | 1 | 2007 | 1701 | 0.030 |
Why?
|
United States | 5 | 2024 | 73144 | 0.030 |
Why?
|
Prevalence | 3 | 2019 | 15868 | 0.030 |
Why?
|
Oxygen | 1 | 2007 | 4273 | 0.030 |
Why?
|
Viral Tropism | 1 | 2016 | 102 | 0.030 |
Why?
|
Receptors, HIV | 1 | 2016 | 159 | 0.030 |
Why?
|
Cervix Uteri | 1 | 2019 | 577 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2012 | 5707 | 0.030 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2008 | 1891 | 0.030 |
Why?
|
Aged | 12 | 2014 | 171544 | 0.030 |
Why?
|
Waist-Hip Ratio | 1 | 2016 | 520 | 0.030 |
Why?
|
Cannabis | 1 | 2021 | 445 | 0.030 |
Why?
|
Cytomegalovirus | 1 | 2019 | 754 | 0.030 |
Why?
|
Oral Health | 1 | 2020 | 493 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2014 | 59683 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2009 | 5802 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2019 | 65365 | 0.030 |
Why?
|
Risk Assessment | 3 | 2014 | 24316 | 0.030 |
Why?
|
Students, Medical | 1 | 2007 | 1964 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2020 | 1197 | 0.030 |
Why?
|
Seroepidemiologic Studies | 1 | 2015 | 405 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2018 | 1051 | 0.030 |
Why?
|
HIV Seropositivity | 1 | 2019 | 962 | 0.030 |
Why?
|
Pilot Projects | 2 | 2023 | 8730 | 0.030 |
Why?
|
Pregnancy Outcome | 1 | 2024 | 2961 | 0.030 |
Why?
|
Speech | 1 | 2018 | 558 | 0.030 |
Why?
|
Cardiovascular Diseases | 2 | 2010 | 15652 | 0.030 |
Why?
|
Waist Circumference | 1 | 2016 | 935 | 0.030 |
Why?
|
Risk Factors | 6 | 2018 | 74954 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2016 | 15939 | 0.030 |
Why?
|
California | 1 | 2016 | 1443 | 0.020 |
Why?
|
Decision Trees | 1 | 2014 | 509 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2020 | 22292 | 0.020 |
Why?
|
Receptors, CXCR4 | 1 | 2016 | 729 | 0.020 |
Why?
|
Metabolomics | 1 | 2020 | 1675 | 0.020 |
Why?
|
Mitochondria | 1 | 2024 | 3675 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2009 | 9433 | 0.020 |
Why?
|
Vitamin D | 1 | 2024 | 3311 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2024 | 26410 | 0.020 |
Why?
|
Treatment Failure | 1 | 2016 | 2664 | 0.020 |
Why?
|
Transcription Factors | 1 | 2009 | 12166 | 0.020 |
Why?
|
Mental Health | 1 | 2024 | 3276 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 1 | 2009 | 221 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2006 | 9261 | 0.020 |
Why?
|
Age Factors | 2 | 2019 | 18472 | 0.020 |
Why?
|
Prognosis | 4 | 2010 | 30020 | 0.020 |
Why?
|
Research Design | 1 | 2024 | 6209 | 0.020 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2008 | 91 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2009 | 39405 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2014 | 12557 | 0.020 |
Why?
|
Psychometrics | 1 | 2016 | 3069 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4286 | 0.020 |
Why?
|
Opioid-Related Disorders | 1 | 2021 | 2188 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 2006 | 363 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 11854 | 0.020 |
Why?
|
Body Mass Index | 2 | 2016 | 13050 | 0.020 |
Why?
|
Biological Availability | 1 | 2006 | 392 | 0.020 |
Why?
|
Half-Life | 1 | 2006 | 650 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9380 | 0.010 |
Why?
|
Electric Impedance | 1 | 2009 | 795 | 0.010 |
Why?
|
Child Development | 1 | 2016 | 2334 | 0.010 |
Why?
|
Educational Status | 1 | 2011 | 2518 | 0.010 |
Why?
|
Leukocytosis | 1 | 2005 | 250 | 0.010 |
Why?
|
Organ Size | 1 | 2009 | 2268 | 0.010 |
Why?
|
China | 1 | 2010 | 2389 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 7145 | 0.010 |
Why?
|
Intra-Abdominal Fat | 1 | 2008 | 624 | 0.010 |
Why?
|
Infant | 2 | 2016 | 36512 | 0.010 |
Why?
|
Alanine Transaminase | 1 | 2006 | 604 | 0.010 |
Why?
|
Polysomnography | 1 | 2010 | 1865 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13646 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9681 | 0.010 |
Why?
|
Cognition | 1 | 2020 | 7074 | 0.010 |
Why?
|
Drug Synergism | 1 | 2006 | 1760 | 0.010 |
Why?
|
Comprehension | 1 | 2007 | 641 | 0.010 |
Why?
|
Retrospective Studies | 4 | 2014 | 81768 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 13038 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2006 | 2226 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3811 | 0.010 |
Why?
|
Health Surveys | 1 | 2011 | 4056 | 0.010 |
Why?
|
Down-Regulation | 1 | 2008 | 2937 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21544 | 0.010 |
Why?
|
Species Specificity | 1 | 2005 | 2417 | 0.010 |
Why?
|
Time Factors | 2 | 2014 | 40267 | 0.010 |
Why?
|
Teaching | 1 | 2007 | 1172 | 0.010 |
Why?
|
Postmenopause | 1 | 2009 | 2518 | 0.010 |
Why?
|
Catheterization | 1 | 2005 | 1431 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10863 | 0.010 |
Why?
|
Regression Analysis | 1 | 2009 | 6350 | 0.010 |
Why?
|
Body Composition | 1 | 2008 | 2461 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2006 | 21163 | 0.010 |
Why?
|
Paclitaxel | 1 | 2006 | 1736 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16716 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2009 | 3457 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2006 | 4859 | 0.010 |
Why?
|
Administration, Oral | 1 | 2006 | 4043 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15455 | 0.010 |
Why?
|
Depression | 1 | 2016 | 8241 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2005 | 1890 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2006 | 2060 | 0.010 |
Why?
|
Bone Density | 1 | 2009 | 3559 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2006 | 2588 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2006 | 4921 | 0.010 |
Why?
|
Quality of Life | 1 | 2016 | 13499 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 10776 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2005 | 12092 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2008 | 10377 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2005 | 3800 | 0.010 |
Why?
|
Hospitalization | 1 | 2008 | 10844 | 0.000 |
Why?
|
Aging | 1 | 2005 | 8764 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 36849 | 0.000 |
Why?
|
Concepts
(231)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_